ES543691A0 - Procedimiento para preparar nuevos n-sustituido-2-(1-imida- zolil)-indoles - Google Patents

Procedimiento para preparar nuevos n-sustituido-2-(1-imida- zolil)-indoles

Info

Publication number
ES543691A0
ES543691A0 ES543691A ES543691A ES543691A0 ES 543691 A0 ES543691 A0 ES 543691A0 ES 543691 A ES543691 A ES 543691A ES 543691 A ES543691 A ES 543691A ES 543691 A0 ES543691 A0 ES 543691A0
Authority
ES
Spain
Prior art keywords
zolil
imida
indoles
substituted
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES543691A
Other languages
English (en)
Other versions
ES8608514A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of ES8608514A1 publication Critical patent/ES8608514A1/es
Publication of ES543691A0 publication Critical patent/ES543691A0/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES543691A 1982-09-30 1985-05-30 Procedimiento para preparar nuevos n-sustituido-2-(1-imida- zolil)-indoles Expired ES8608514A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/430,644 US4436746A (en) 1982-09-30 1982-09-30 Thromboxane synthetase inhibitory N-substituted-2-(1-imidazolyl)indoles

Publications (2)

Publication Number Publication Date
ES8608514A1 ES8608514A1 (es) 1986-06-16
ES543691A0 true ES543691A0 (es) 1986-06-16

Family

ID=23708431

Family Applications (2)

Application Number Title Priority Date Filing Date
ES526120A Expired ES8600276A1 (es) 1982-09-30 1983-09-29 Procedimiento para preparar nuevos n-sustituido-2-(1-imidazolil)-indoles
ES543691A Expired ES8608514A1 (es) 1982-09-30 1985-05-30 Procedimiento para preparar nuevos n-sustituido-2-(1-imida- zolil)-indoles

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES526120A Expired ES8600276A1 (es) 1982-09-30 1983-09-29 Procedimiento para preparar nuevos n-sustituido-2-(1-imidazolil)-indoles

Country Status (10)

Country Link
US (1) US4436746A (es)
EP (1) EP0107618B1 (es)
JP (1) JPS5982385A (es)
AU (1) AU1971683A (es)
CA (1) CA1207327A (es)
DE (1) DE3364528D1 (es)
DK (1) DK448783A (es)
ES (2) ES8600276A1 (es)
FI (1) FI833489A (es)
GR (1) GR81266B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4539410A (en) * 1982-09-30 1985-09-03 Ciba-Geigy Corporation N-Substituted-2-(1-imidazolyl)indoles
US4511573A (en) * 1983-05-17 1985-04-16 Ciba-Geigy Corporation 3-Substituted-2-(heteroaryl) indoles
US4675332A (en) * 1984-12-10 1987-06-23 Warner-Lambert Company Acidic tetrazolyl substituted indole compounds and their use as antiallergy agents
GB8707051D0 (en) * 1986-04-15 1987-04-29 Ici America Inc Heterocyclic carboxamides
GB8609175D0 (en) * 1986-04-15 1986-05-21 Ici America Inc Heterocyclic carboxamides
US6406713B1 (en) 1987-03-05 2002-06-18 The Liposome Company, Inc. Methods of preparing low-toxicity drug-lipid complexes
US5616334A (en) * 1987-03-05 1997-04-01 The Liposome Company, Inc. Low toxicity drug-lipid systems
NZ223660A (en) * 1987-03-05 1990-11-27 Liposome Co Inc Low toxicity drug-lipid complexes; methods of making them; and method of determining their toxicity
DE4010797A1 (de) * 1990-04-04 1991-10-10 Hoechst Ag Substituierte azole, verfahren zu deren herstellung, diese enthaltende mittel und deren verwendung
GB9022858D0 (en) * 1990-10-20 1990-12-05 Reckitt & Colmann Prod Ltd Derivatives of indoles
GB9101375D0 (en) * 1991-01-22 1991-03-06 Erba Carlo Spa N-imidazolyl derivatives of substituted tetrahydrocarbazole and cyclohepht(b)indole

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3370063A (en) 1964-10-05 1968-02-20 Mcneilab Inc Substituted dimethoxy indoles and method of making the same
US4059583A (en) 1975-11-13 1977-11-22 Mcneil Laboratories, Incorporated Substituted indoles
US4140858A (en) 1977-12-19 1979-02-20 Warner-Lambert Company 3-(1H-imidazol-1-ylmethyl)-2-(disubstitutedaminomethyl)indoles and a method for their production
EP0003901B1 (en) 1978-02-24 1981-08-05 Pfizer Limited 3-(imidazol-1-ylalkyl)indoles as selective inhibitors of thromboxane synthetase,pharmaceutical compositions thereof, and methods for preparing them
IT1162310B (it) * 1978-05-02 1987-03-25 Ono Pharmaceutical Co Derivati di imidazolo e procedimento per produrli
DK151884C (da) 1979-03-07 1988-06-13 Pfizer Analogifremgangsmaade til fremstilling af 3-(1-imidazolylalkyl)indolderivater eller farmaceutisk acceptable syreadditionssalte deraf
US4436911A (en) * 1981-05-12 1984-03-13 William H. Rorer, Inc. Heterocyclic amidinoureas

Also Published As

Publication number Publication date
US4436746A (en) 1984-03-13
FI833489A0 (fi) 1983-09-28
ES8608514A1 (es) 1986-06-16
EP0107618B1 (en) 1986-07-16
EP0107618A1 (en) 1984-05-02
CA1207327A (en) 1986-07-08
DK448783D0 (da) 1983-09-29
ES526120A0 (es) 1985-10-01
AU1971683A (en) 1984-04-05
DE3364528D1 (de) 1986-08-21
JPS5982385A (ja) 1984-05-12
GR81266B (es) 1984-12-11
FI833489A (fi) 1984-03-31
DK448783A (da) 1984-03-31
ES8600276A1 (es) 1985-10-01

Similar Documents

Publication Publication Date Title
ES526780A0 (es) Procedimiento para preparar nuevos compuestos azolicos
ES534787A0 (es) Procedimiento para preparar etinglicoles
AR231137A1 (es) Procedimiento para preparar metoxifenetilimidazoles
ES543086A0 (es) Procedimiento para preparar nuevos 2-fenil-imidazoles
ES533995A0 (es) Procedimiento para preparar imidasoles
AR240941A1 (es) Procedimiento para preparar compuestos de pirazolopirimidinas
ES523064A0 (es) Procedimiento para preparar azetidinas.
AR230457A1 (es) Procedimiento para producir s-adenosilmetionina
MX158200A (es) Procedimiento para preparar dimetileter
ES523938A0 (es) Procedimiento para preparar n-fosfonometilglicina
ES534227A0 (es) Procedimiento para preparar piridinas
MX163078B (es) Procedimiento mejorado para formar nitroparafinas
ES526120A0 (es) Procedimiento para preparar nuevos n-sustituido-2-(1-imidazolil)-indoles
AR226634A1 (es) Procedimiento para preparar cligolaldehido
ES523372A0 (es) Procedimiento para preparar compuestos disazoicos metalizados
ES502851A0 (es) Procedimiento para preparar n6-adenosina
ES521813A0 (es) Procedimiento para preparar alcohil-polisacaridos.
ES500738A0 (es) Procedimiento para preparar pirimidil-quinazolinas
ES520531A0 (es) Procedimiento para preparar tioeteres.
MX6807E (es) Procedimiento para preparar oxaquinolicidinas
MX6699E (es) Procedimiento para preparar acil-ureas
ES530037A0 (es) Procedimiento para preparar imidazolamidas
ES525235A0 (es) Procedimiento para preparar n-fosfonometilglicina
ES525085A0 (es) Procedimiento para preparar n-alil-olalquil-tionocarbamatos
ES533024A0 (es) Procedimiento para preparar meta-o para-isopropenil-alfa-alfa-dimetilbencilamina